Business

Glenmark to start new phase 3 clinical trial for hospitalised patients of moderate COVID-19

ANI | May 26, 2020 11:01 AM
Glenmark ranks among the top 80 pharma and biotech companies of the world in terms of revenue.

Mumbai (Maharashtra) [India], May 26 (ANI): Glenmark Pharmaceuticals on Tuesday announced a new randomised, open-label study to test the combined efficacy of two antiviral drugs Favipiravir and Umifenovir as a potential COVID-19 treatment strategy.

The two antiviral drugs have a different mechanism of action, and their combination may demonstrate improved treatment efficacy by effectively tackling high viral loads in patients during an early stage of the disease, said the pharma major in a statement.

Monika Tandon, Vice President and Head for Clinical Development Global Specialty and Branded Portfolio, said combining antiviral agents that have a good safety profile and act on different stages of viral life-cycle is an effective treatment approach to rapidly suppress initial high viral load and lead to an overall improvement in clinical parameters.

"We consider Glenmark's study will be pivotal in leading to the identification of highly effective and safe treatments against COVID-19 in India," she said.

"Beyond its many potential patient treatment benefits, we also hope the combination therapy will reduce infection risk among medical professionals and healthcare workers by reducing the duration of virus shedding from treated patients."

A total of 158 hospitalised patients of moderate COVID-19 infection will be enrolled in the combination study and randomised in two groups.

Simultaneously, Glenmark is also conducting phase 3 clinical trials of Favipiravir as a COVID-19 monotherapy option with 150 patients, enrolled from nine leading government and private hospitals across the country. So far, 30 patients have been randomised.Glenmark Pharmaceuticals is a global research-led company with presence across generics, speciality and OTC business with operations in over 50 countries. Its key therapy focus areas globally are respiratory, dermatology and oncology. (ANI)

Have something to say? Post your comment
Must Read
Under Ghar-Ghar Rozgar Mission, Sunder Sham Arora distributes 38 e-rickshaws worth Rs. 50 lakh to needy women
Under Ghar-Ghar Rozgar Mission, Sunder Sham Arora distributes 38 e-rickshaws worth Rs. 50 lakh to needy women
Batala Migrant labourer commits suicide due to economic hardship amid Covid-19
Batala Migrant labourer commits suicide due to economic hardship amid Covid-19
Best performing districts honoured under family planning program on ‘World Population Day’
Best performing districts honoured under family planning program on ‘World Population Day’
Citing Covid situation, Punjab CM writes to PM urging review of UGC guidelines on exams
Citing Covid situation, Punjab CM writes to PM urging review of UGC guidelines on exams
In view of water accumulation on roads, Bharat Bhushan Ashu takes round of city & issues necessary instructions
In view of water accumulation on roads, Bharat Bhushan Ashu takes round of city & issues necessary instructions
DC directs health department to start using new Rapid antigen testing kits for all symptomatic and SARI patients
DC directs health department to start using new Rapid antigen testing kits for all symptomatic and SARI patients
Lood protection works to be completed by next week-DC
Lood protection works to be completed by next week-DC
Monty Sehgal appointed as BJP state executive member
Monty Sehgal appointed as BJP state executive member
Education Department starts "On Line District level Grievances Redressal Meetings"
Education Department starts "On Line District level Grievances Redressal Meetings"
Banks NPAs set to rise, must raise capital to build resilience: RBI Governor
Banks NPAs set to rise, must raise capital to build resilience: RBI Governor
Entire top brass of Jalandhar administration to be quarantined as secretary RTA detected Corona positive
Entire top brass of Jalandhar administration to be quarantined as secretary RTA detected Corona positive
COVID-19 biggest test of financial system's resilience: RBI Governor Das
COVID-19 biggest test of financial system's resilience: RBI Governor Das